Want to see HCA full AI Analyst Report?
Revenue by Segment
Breaks down income from various business areas, revealing which segments are growing or declining and indicating strategic focus or market demand shifts.Regional revenue shows multi-quarter, structural growth driven by network and outpatient expansion, but recent sequential softness in the American and National groups (vs. continued resilience in Atlantic) tracks management’s exchange disenrollment and elective-surgery headwinds; Corporate & Other’s large quarter-to-quarter swing reads like timing/one‑off activity rather than core demand. In short, volumes ex-exchange and Medicaid supplemental payments are propping revenue, yet payer‑mix shifts create a meaningful near‑term EBITDA and cash‑flow risk investors should price in.
Date | Corporate and Other | National Group | American Group | Atlantic Group |
|---|---|---|---|---|
Jun 30, 2026 | $824.00M | $5.25B | $6.58B | $7.57B |
Mar 31, 2026 | $859.00M | $5.32B | $6.57B | $6.36B |
Dec 31, 2025 | $814.00M | $5.49B | $6.93B | $6.28B |
Sep 30, 2025 | $806.00M | $5.53B | $6.69B | $6.14B |
Jun 30, 2025 | $790.00M | $5.20B | $6.49B | $6.12B |
Mar 31, 2025 | $758.00M | $5.07B | $6.33B | $6.17B |
Dec 31, 2024 | $287.00M | $5.11B | $6.69B | $6.20B |
Sep 30, 2024 | $999.00M | $4.89B | $6.02B | $5.58B |
Jun 30, 2024 | $978.00M | $4.82B | $5.98B | $5.72B |
Mar 31, 2024 | $953.00M | $4.79B | $5.91B | $5.68B |